Email this article Features of Legal Regulation of the Names of Biomedical Cell Products
- Authors: Davidenko A.O.1
-
Affiliations:
- Educational Institution of the Trade Unions of Higher Professional Education “Academy of Labor and Social Relations” (OUP VO “ATiSO”)
- Issue: Vol 12, No 2 (2022)
- Pages: 55-59
- Section: Articles
- URL: https://ogarev-online.ru/2223-0092/article/view/146949
- DOI: https://doi.org/10.33693/2223-0092-2022-12-2-55-59
- ID: 146949
Cite item
Open Access
Access granted
Subscription Access
Abstract
Today, the rapid development of science and technology has led to the development of new, completely different technologies, different from traditional ones. First, it affected the sphere of biotechnology. A lot of research is being done to create biomedical cell products. However, the introduction of such products into production and their practical application involves a number of legal issues, including the naming of biomedical cell products. The relevance of the topic of this study is because in the Russian Federation, the legal regulation of BMCP is at an early stage, but this issue is of great importance for the introduction of such products and their certification on the market. The purpose of the study is to consider the features of the legal regulation of the names of biomedical cell products. Research methodology: analysis of the legal regulation of the names of biomedical cell products. The novelty of the study lies in the consideration of the features of the legal regulation of the names of biomedical cell products
Full Text
##article.viewOnOriginalSite##About the authors
Anastasia O. Davidenko
Educational Institution of the Trade Unions of Higher Professional Education “Academy of Labor and Social Relations” (OUP VO “ATiSO”)
Email: nastya.anastasya96@yandex.ru
postgraduate student at the Department of Civil Law and Procedure Moscow, Russian Federation
References
- Federal Law No. 180-FZ of 26.06.2016 “On biomedical cell products” [Electronic resource]. URL:http://pravo.gov.ru/proxy/ips/?docbody=&nd=102402596
- Decree of the Government of the Russian Federation of 28.12.2012 No. 2580-r “Strategy for the development of medical science for the period up to 2025” [Electronic resou- rce]. URL:https://minzdrav.gov.ru/ministry/61/23/stranitsa-967/strategiya-razvitiya-meditsinskoy-nauki-v-rossiyskoy-federatsii-na-period-do-2025-goda
- Bolshakova O.B. Features of the production and registration of BMCP in Russia. Bulletin of the Russian Scientific Center of Radiology of the Ministry of Health of Russia. 2021. Vol. 21. No. 2. Pp. 1-24. (In Rus.)
- Ivanov D.V., Chabanenko A.V. The law on cellular products: breakthrough or defeat? Bulletin of New Medical Technologies. 2017. Vol. 24. No. 4. Pp. 166-176. (In Rus.)
- More than 30 biomedical cell products are ready for registration [Electronic resource]. URL:https://ria.ru/science/20161228/1484843065.html
- The Ministry of Health has authorized a clinical trial of the first BMCP in Russia [Electronic resource]. URL:https://pharmprom.ru/minzdrav-razreshil-provedenie-klinicheskogo-ispytaniya-pervogo-v-rossii-bmkp
- Mokhov A.A. Preferential use of medicines under international nonproprietary names in Russian practice: pros and cons. Medical Law. 2014. Vol. 1. Pp. 9-15. (In Rus.)
- Olefir Yu.V. Nomenclature of biomedical cell products. Remedium. Magazine about the Russian Market of Medicines and Medical Equipment. 2017. No. 3. Pp. 6-11. (In Rus.)
- Solonitsyna L.A., Sazonov S.V., Leontiev S.L. Analysis of the main provisions of Federal Law No. 180-FZ “On biomedical cell products”. Bulletin of the Ural Medical Academic Science. 2017. Vol. 14. No. 1. Pp. 104-110. (In Rus.)
Supplementary files
